Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v3.22.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities:    
Net income $ 19,208 $ 5,504
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for loan losses 16,579 12,319
Depreciation and amortization 4,810 5,189
Share-based compensation expense 745  
Net losses on sales of real estate and property and equipment 5 11
Increase (Decrease) in deferred income tax liability 5,273 (4,440)
Changes in operating assets and liabilities:    
Notes receivable (23,874) (4,534)
VOI Inventory 7,898 2,032
Prepaid expense and other assets (6,976) (15,192)
Accounts payable, accrued liabilities and other, and deferred income 5,824 11,080
Net cash provided by operating activities 29,492 11,969
Investing activities:    
Purchases of property and equipment (4,895) (4,049)
Net cash used in investing activities (4,895) (4,049)
Financing activities:    
Repayments of notes payable and other borrowings (33,970) (63,484)
Proceeds from notes payable and other borrowings 58,397 42,350
Redemption of junior subordinated debentures   (4,004)
Payments for debt issuance costs (1,697)  
Purchase and retirement of common stock (4,702)  
Net cash provided by (used in) financing activities 18,028 (25,138)
Net increase (decrease) in cash and cash equivalents and restricted cash 42,625 (17,218)
Cash, cash equivalents and restricted cash at beginning of period 183,079 257,104
Cash, cash equivalents and restricted cash at end of period 225,704 239,886
Supplemental cash flow information:    
Interest paid on borrowings, net of amounts capitalized 5,951 1,818
Income taxes paid 704 228
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 179,274 199,150
Restricted cash 46,430 40,736
Total cash, cash equivalents, and restricted cash $ 225,704 $ 239,886